Medical significance of peroxisome proliferator-activated receptors
- 1 July 1999
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 354 (9173), 141-148
- https://doi.org/10.1016/s0140-6736(98)10364-1
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γPublished by Elsevier BV ,1999
- Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte DifferentiationThe New England Journal of Medicine, 1998
- The Peroxisome Proliferator-Activated Receptor α (PPARα) Ligand WY 14,643 Does Not Interfere with Leukotriene B4 Induced Adhesion of Neutrophils to Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- Up-Regulation of UCP-2 Gene Expression by PPAR Agonists in Preadipose and Adipose CellsBiochemical and Biophysical Research Communications, 1997
- TroglitazoneDrugs, 1997
- The Orphan Nuclear Hormone Receptor LXRα Interacts with the Peroxisome Proliferator-activated Receptor and Inhibits Peroxisome Proliferator SignalingPublished by Elsevier BV ,1996
- Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.JCI Insight, 1995
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Effect of various n − 3/n − 6 fatty acid ratio contents of high fat diets on rat liver and heart peroxisomal and mitochondrial β-oxidationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)Biology of the Cell, 1993